Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation

This publication has 67 references indexed in Scilit:

• Bim and Bad mediate imatinib-induced killing of Bcr/Abl ⁺ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic
  Proceedings of the National Academy of Sciences, 2006
• Interrelated Roles for Mcl-1 and BIM in Regulation of TRAIL-mediated Mitochondrial Apoptosis
  Journal of Biological Chemistry, 2006
• Low-Level Expression of Proapoptotic Bcl-2–Interacting Mediator in Leukemic Cells in Patients with Chronic Myeloid Leukemia: Role of BCR/ABL, Characterization of Underlying Signaling Pathways, and Reexpression by Novel Pharmacologic Compounds
  Cancer Research, 2005
• Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis
  Oncogene, 2004
• Roles of Bim in Apoptosis of Normal and Bcr-Abl-Expressing Hematopoietic Progenitors
  Molecular and Cellular Biology, 2004
• The biology of CML blast crisis
  Blood, 2004
• Downregulation of Bim, a Proapoptotic Relative of Bcl-2, Is a Pivotal Step in Cytokine-Initiated Survival Signaling in Murine Hematopoietic Progenitors
  Molecular and Cellular Biology, 2001
• Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
  Science, 1990
• The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
  Science, 1986
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
  Nature, 1985